MCK slides nearly 4% as selling pressure persists despite bullish technicals and raised outlook

MCK slides nearly 4% as selling pressure persists despite bullish technicals and raised outlook
McKesson slides 3.83% to $1042.88 today

McKesson Corporation (MCK) fell 3.83% after an intraday sell-off, even as the company reported strong segment growth and completed major acquisitions. The drop contradicts the ongoing bullish price structure, with MCK trading above all its major moving averages.

MCK price prediction
24H -0.26%
$1,059.45
48H -0.32%
$1,058.8
7D -2.31%
$1,037.62
1M 6.81%
$1,134.54
3M 7.25%
$1,139.2
6M 13.62%
$1,206.82
12M 17.15%
$1,244.31
Current price: $1,062.16 -22.0500 2.03%
Closed 11/19
Daily range 1042.88 Arrow from to Icon 1082.59
Weekly range 1073.34 Arrow from to Icon 1117.82
Loading...

Highlights

  • McKesson completed the acquisition of Precision Medicine Group and took a minority stake in Option Care Health to expand its clinical and infusion business.
  • Oncology and multispecialty segment revenue reached $48.4 billion for fiscal 2026 with 31.4% growth, while quarterly earnings per share of $11.68 and revenue of $110.96 billion exceeded forecasts.
  • Shares of McKesson declined 3.83% today despite ongoing bullish momentum, with the stock expected to trade between $1,020 and $1,066 over the next week.

Earnings beat and acquisitions fail to lift shares amid selling pressure

McKesson recently closed its acquisition of Precision Medicine Group in early November 2026, expanding its reach into clinical research and home infusion services. The company also agreed to acquire a minority stake in Option Care Health, a leader in home and alternate site infusion. Precision Medicine Group will report under McKesson’s oncology and multispecialty segment, which generated $48.4 billion in fiscal 2026 with 31.4% growth. Quarterly earnings per share came in at $11.68 and revenue at $110.96 billion, both above analyst estimates, accompanied by a raised full-year profit forecast and a declared dividend of $0.94 per share, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, remains cautious despite McKesson’s recent positive earnings beat and acquisitions. He believes the sharp 3.83% slide, even as the stock trades well above major averages, signals underlying selling pressure and possible overextension. The technicals show bullish alignment, but neutral oscillator readings and the volatility spike highlight market indecision. He sees risk that positive news is not being fully priced in, suggesting buyers may be hesitant at these highs. "Unless demand picks up and the price holds above $1,039, I see limited upside and potential for deeper retracement."
Viktoras Karapetjanc, expert at Traders Union, views McKesson’s fundamentals as strong following robust earnings and strategic acquisitions. He emphasizes that the raised guidance and expansion into high-growth segments reinforce long-term bullishness. The analyst sees last session’s drop as short-term noise in a structurally healthy bull market. "I am confident the bullish structure remains intact, and further growth toward $1,066 looks likely given McKesson’s momentum and sector leadership."
Jainam Mehta, market strategist, observes that McKesson’s short-term volatility contrasts with its positive multi-timeframe technicals. He notes that a gap down on strong news may offer a tactical entry if support near $1,039 holds. The analyst favors a scenario-based approach, watching for either a reversal above resistance or downside extension. "If sentiment stabilizes, I see potential for a swift breakout move targeting $1,057 or higher."
McKesson Corporation asset chart
McKesson Corporation price dynamics. Source: TradingView.

Bullish trend persists as volatility spikes and momentum remains strong

MCK is trading above the 20-day ($1,039), 50-day ($967.15), and 200-day ($878.07) moving averages, pointing to a bullish structure in the short, medium, and long term. The immediate resistance is at $1,057, while support sits at the 20-day average of $1,039, with bullish alignment confirmed by the 50-day versus 200-day trend. Momentum indicators, including positive MACD and strong ADX readings, highlight ongoing strength. However, the RSI, Stochastic RSI, and CCI are all neutral, indicating a balanced oscillator position. Bull/Bear Power remains positive intraday. The session has seen a sharp decline of 3.83%, with an intraday downside gap and volatility at 2.39%, as selling pressure dominated trading despite the broader bullish trend indicators.

In a recent review, analysts emphasized that McKesson was favored for its strong profitability and valuation discipline during a higher interest rate environment. The latest market reaction, marked by a sharp intraday decline despite robust earnings and expansion activity, introduces near-term volatility that makes the $1,039 support level crucial for traders assessing the risk of a deeper pullback.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.